Videos
Treating Early-Stage Alzheimer’s Disease: Newly Available Treatments and What They Mean for Patients
This hour-long online session features two leading doctors, a representative from BrightFocus, and a person with AD who will help caregivers and patients understand newly approved therapies that treat Alzheimer's disease (AD) itself, not just the symptoms.
Learn more about the importance of early detection by watching a recording of, “A Brighter Future with Alzheimer’s Disease: Understanding Why Early Detection Matters and What It Means for Treatment.” This free, hourlong online presentation is produced by Alzheimer’s Disease Research, a BrightFocus Foundation program, and Medlive.
Ilyas Washington, PhD, co-founder of biOOrg3.14 LLC & Alkeus Pharmaceuticals, Inc, helped develop a potential new treatment for Stargardt disease, an inherited condition similar to age-related macular degeneration, that received an FDA “Breakthrough Therapy” designation.
Jason Meyer, PhD, is a BrightFocus Foundation success story and a pioneer in the effort to regenerate eye tissue that is damaged by glaucoma.
Theresa Mabe shares her story and coping strategies for living with myopic macular degeneration.
Learn about Jill's experience with dry and wet macular degeneration.
Dr. Gokoffski from the USC Roski Eye Institute expresses her gratitude for the research she was able to achieve thanks to the donors of BrightFocus Foundation.
Alzheimer's can affect anyone, and can take a toll on families and caregivers.